Know Cancer

or
forgot password

Bangladesh Vitamin E and Selenium Trial


N/A
25 Years
65 Years
Open (Enrolling)
Both
Non-melanoma Skin Cancer

Thank you

Trial Information

Bangladesh Vitamin E and Selenium Trial


Inclusion Criteria:



- Manifest arsenic skin lesions (melanosis, leucomelanosis, or keratosis)

- Aged 25 to 65 years

- Permanent resident of study area

Exclusion Criteria:

- Pregnancy

- Clinically too ill (enlarged spleen or liver)

- Presence of gangrene

- Cancer

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention

Outcome Measure:

Skin Cancer

Outcome Time Frame:

Incidence during the 6-year study period

Safety Issue:

No

Principal Investigator

Habibul Ahsan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Chicago

Authority:

Bangladesh: Ethical Review Committee

Study ID:

15091A (R01-CA10743-1)

NCT ID:

NCT00392561

Start Date:

April 2006

Completion Date:

June 2016

Related Keywords:

  • Non-melanoma Skin Cancer
  • Skin Neoplasms
  • Carcinoma, Basal Cell
  • Carcinoma, Basosquamous
  • Carcinoma, Squamous Cell

Name

Location